On the recordMarch 28, 2023
I am concerned that the lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Source
congress.govI am concerned that the lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Collins expresses concern over the impact of reduced in-person meetings on FDA's effectiveness.
Share
More from Susan Collins
“It’s appalling to me that some of the rhetoric is coming from public officials on both sides of the aisle who should know better than to levy personal and political attacks against the judiciary and the court specifically,” Collins said.
It has not had an impact on the state of Maine, in that Maine has actually expanded its law.